Cite
van Ramshorst MS, van der Heiden-van der Loo M, Dackus GM, et al. Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer. Breast Cancer Res Treat. 2016;159(2):393doi: 10.1007/s10549-016-3941-6.
van Ramshorst, M. S., van der Heiden-van der Loo, M., Dackus, G. M., Linn, S. C., & Sonke, G. S. (2016). Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer. Breast cancer research and treatment, 159(2), 393. https://doi.org/10.1007/s10549-016-3941-6
van Ramshorst, Mette S, et al. "Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer." Breast cancer research and treatment vol. 159,2 (2016): 393. doi: https://doi.org/10.1007/s10549-016-3941-6
van Ramshorst MS, van der Heiden-van der Loo M, Dackus GM, Linn SC, Sonke GS. Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer. Breast Cancer Res Treat. 2016 Sep;159(2):393. doi: 10.1007/s10549-016-3941-6. PMID: 27534944.
Copy
Download .nbib